[FGF23-related hypophosphatemic rickets/osteomalacia]
Related Experiment Video
Updated: Jul 11, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
1University of Tokyo Hospital, Department of Internal Medicine, Division of Nephrology and Endocrinology.
Abstract:
Fibroblast growth factor (FGF) 23 is a humoral factor that reduces serum phosphate and 1,25-dihydroxyvitamin D [1,25 (OH)(2)D] levels at least in part by suppressing proximal tubular phosphate reabsorption and 1,25 (OH)(2)D production. It has been shown that several hypophosphatemic diseases characterized by impaired phosphate reabsorption, relatively low 1,25 (OH)(2)D and rickets/osteomalacia are caused by excess actions of FGF23. Measurement of circulatory FGF23 levels seems to be useful for diagnosis of these hypophosphatemic diseases. Novel therapeutic methods for these diseases may be developed by finding maneuvers to modulate FGF23 actions.
Related Concept Videos
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily regulated...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
What is the Skeletal System?
Introduction to Electrolytes
Role of Sodium
One...
Chronic Kidney Disease II: Clinical Manifestations
Bone Remodeling
